Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...

Ashwini Nadkarni, MD, of Mass General Brigham, discusses what’s new in the management of generalized anxiety disorder.

Dr Bradley N. Gaynes reflects on how the understanding and treatment of generalized anxiety disorder (GAD) has evolved over the past three decades. One major advance has been the improved ability to ...

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Small Cap ...

Ashwini Nadkarni, MD, of Mass General Brigham, discusses how the treatment landscape has changed in recent years for generalized anxiety disorder.

Lily A. Brown, PhD, describes a patient with generalized anxiety disorder (GAD) who sought urgent consultation despite prior evaluations by multiple clinicians internationally. The patient’s continued ...

The U.S. Food and Drug Administration last week granted “breakthrough therapy” status to a form of the psychedelic drug LSD as a treatment for anxiety. The drug, a form of LSD (lysergide d-tartrate) ...

In a world of constant connectivity and mounting pressures, generalized anxiety disorder (GAD) has emerged as a significant mental health challenge affecting millions. Recent studies show that anxiety ...

Everyone has anxiety, but an anxiety disorder is another thing entirely. Here's what women need to know about worry gone wild ...

Some anxiety is part of the cost of admission to humanity. Because its distinguishing raison d’etre is the anticipation of bad outcomes, it can be a helpful stimulus to preparation or rehearsal before ...